AlphaQuest LLC Has $411,000 Stake in Orthofix Medical Inc. $OFIX

Key Points

• AlphaQuest LLC significantly increased its stake in Orthofix Medical by 258.1% in the 1st quarter, owning a total of 25,202 shares valued at approximately $411,000.
• Institutional investors and hedge funds currently hold 89.76% of Orthofix Medical’s stock, with several funds such as Lazard Asset Management and US Bancorp DE also increasing their positions.
• Orthofix Medical reported a quarterly loss of ($0.36) earnings per share, missing estimates by ($0.40), while generating revenue of $203.12 million for the quarter.

AlphaQuest LLC increased its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 258.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,202 shares of the medical device company's stock after purchasing an additional 18,165 shares during the quarter. AlphaQuest LLC owned approximately 0.06% of Orthofix Medical worth $411,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in OFIX. Lazard Asset Management LLC bought a new stake in Orthofix Medical during the fourth quarter worth $45,000. US Bancorp DE raised its position in Orthofix Medical by 684.6% during the first quarter. US Bancorp DE now owns 5,673 shares of the medical device company's stock worth $93,000 after acquiring an additional 4,950 shares in the last quarter. Tower Research Capital LLC TRC raised its position in Orthofix Medical by 120.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 8,458 shares of the medical device company's stock worth $148,000 after acquiring an additional 4,627 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new stake in Orthofix Medical during the first quarter worth $164,000. Finally, State of Wyoming raised its position in Orthofix Medical by 206.8% during the fourth quarter. State of Wyoming now owns 9,432 shares of the medical device company's stock worth $165,000 after acquiring an additional 6,358 shares in the last quarter. Institutional investors and hedge funds own 89.76% of the company's stock.

Orthofix Medical Stock Performance

Shares of OFIX traded up $0.24 during trading hours on Monday, hitting $14.98. The company had a trading volume of 534,055 shares, compared to its average volume of 536,330. The firm has a market cap of $591.56 million, a price-to-earnings ratio of -4.73 and a beta of 0.86. The business has a fifty day moving average of $12.25 and a 200-day moving average of $13.41. Orthofix Medical Inc. has a 12 month low of $10.24 and a 12 month high of $20.73. The company has a quick ratio of 1.50, a current ratio of 2.67 and a debt-to-equity ratio of 0.38.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The medical device company reported ($0.36) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.40). Orthofix Medical had a negative net margin of 15.29% and a negative return on equity of 25.43%. The business had revenue of $203.12 million during the quarter, compared to analyst estimates of $196.89 million. Orthofix Medical has set its FY 2025 guidance at EPS. Equities analysts anticipate that Orthofix Medical Inc. will post -2.81 EPS for the current fiscal year.

Insider Activity at Orthofix Medical

In related news, insider Aviva Mcpherron sold 3,728 shares of the company's stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $10.51, for a total value of $39,181.28. Following the transaction, the insider directly owned 46,322 shares in the company, valued at approximately $486,844.22. This represents a 7.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.30% of the company's stock.

Analysts Set New Price Targets

Several research firms have issued reports on OFIX. Wall Street Zen raised shares of Orthofix Medical from a "sell" rating to a "hold" rating in a research report on Saturday, August 9th. JMP Securities reaffirmed a "market perform" rating on shares of Orthofix Medical in a research report on Friday, June 6th. Finally, Barrington Research raised shares of Orthofix Medical to a "strong-buy" rating and set a $16.00 price target on the stock in a research report on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $21.50.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.